E-ISSN 2231-170X | ISSN 2231-1696
 

Original Article 


Association of DNA damage and dyslipidemia with polycystic ovarian syndrome

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar.

Abstract
Polycystic ovary syndrome (PCOS) is associated with hyperinsulinemia and insulin resistance which may lead to cardio-vascular diseases. Evidence for cardiovascular events in women who were affected by PCOS during fertile age is limited. The pathogenesis is unknown; however, it is a complex multigenetic disorder. The present study was undertaken to evaluate the vari-ous cardiovascular risk factors and their DNA repair efficiency in women with PCOS by investigating the biochemical, endocrinological and molecular cytogenetic alterations. These investigations were carried out in 116 women in the age group of 15-35 years clinically diagnosed with PCOS. Data were compared with that of 50 age-matched healthy normal women. Fasting blood sugar (FBS), Lipid profile, Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH), Prolactin and Estradiol were estimated after getting the informed consent. Mutagen induced chromosome sensitivity analysis was carried out in the lymphocytes of the subjects to assess the DNA repair proficiency. Fasting Blood Sugar, total cholesterol and LDL cholesterol were found to be elevated whereas HDL cholesterol was found to be lowered in the test subjects. FSH, LH and prolactin were also found to be significantly elevated in the test subjects. Change in the estradiol concentration in the test subjects was not significant. The mutagen sensitivity analysis revealed a significant elevation in break per cell (b/c) values indicating a deficiency in the DNA repair mechanism / DNA damage in PCOS patients. Modification of life style by changing the dietary habit and sedentary life style will help to reduce the oxidative stress and may increase the ovarian function and a sensible lifestyle management is recommended for reducing the risk for CVD.

Key words: Polycystic ovary syndrome, Cardiovascular disease, Metabolic syndrome, Type 2 diabetes mellitus, Dyslipidemia, DNA repair mechanism


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by R. Manikkumar
Articles by D. Dinesh Roy
Articles by Viji Krishnan
Articles by T. Vijayakumar
on Google
on Google Scholar

REFERENCES
1 March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544-551 [DOI via Crossref]    [Pubmed]   
2 Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91:4237-4245. [DOI via Crossref]    [Pubmed]   
3 Harwood K, Vuguin P, DiMartino-Nardi J. Current ap-proaches to the diagnosis and treatment of polycystic ovarian syndrome in youth. Horm Res. 2007; 68(5):209-217. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
4 American Heart Association. Heart disease and stroke statistics—2004 Update. Dallas, TX, USA: American Heart Association, 2003
5 Demirbag R, Yilmaz R, Gur M, et al. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syn-drome. Mutat. Res. 2005; 578:298-307. [DOI via Crossref]    [Pubmed]   
6 Guven M, Guven GS, Oz E, Ozaydin A, et al. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels 2007; 22:355-360 [DOI via Crossref]    [Pubmed]   
7 Simon AS, Roy DD, Jayapal V, Vijayakumar T. Somatic DNA damages in cardiovascular autonomic neuropathy. Indian J Clin Biochem. 2011; 26(1):50-56. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
8 Andreassi MG, Barale R, Iozzo P, Picano E. The association of micronucleus frequency with obesity, diabetes and cardiovascular disease. Mutagenesis 2011; 26 (1):77-83. [DOI via Crossref]    [Pubmed]   
9 Svendsen PF, Nilas L, Nørgaard K, Madsbad S. Polycystic ovary syndrome. New patho-physiological discoveries-therapeutic consequences. Ugeskr Laeger. 2005; 167(34):3147-3151. [Pubmed]   
10 Hsu TC, Cherry LM, Saman NAO. Differential Mutagen sensitivity in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet. Cytogenet 1985; 17:307-313. [DOI via Crossref]   
11 Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climateric 2009; 12 (Suppl 1):22–25. [DOI via Crossref]    [Pubmed]   
12 Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607–613 [DOI via Crossref]   
13 Essah PA, Nestler JE, Carmina E. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest 2008; 31:35–41. [DOI via Crossref]    [Pubmed]   
14 Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, Laven JS. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008; 93:470–476. [DOI via Crossref]    [Pubmed]   
15 Rizzo M, Berneis K, Hersberger M, Pepe I, Di Fede G, Rini GB, Spinas GA, Carmina E. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod 2009; 24:2286–2292. [DOI via Crossref]    [Pubmed]   
16 Simon AS, Roy DD, Jayapal V, Vijayakumar T. Biochemical and genetic studies on cardiometabolic syndrome. Indian J Clin Biochem. 2010; 25:164-168. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

How to Cite this Article
Pubmed Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. J Med Allied Sci. 2013; 3(1): 15-21.


Web Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. https://jmas.in/?mno=210697 [Access: January 12, 2023].


AMA (American Medical Association) Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. J Med Allied Sci. 2013; 3(1): 15-21.



Vancouver/ICMJE Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. J Med Allied Sci. (2013), [cited January 12, 2023]; 3(1): 15-21.



Harvard Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar (2013) Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. J Med Allied Sci, 3 (1), 15-21.



Turabian Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. 2013. Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. Journal of Medical and Allied Sciences, 3 (1), 15-21.



Chicago Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. "Association of DNA damage and dyslipidemia with polycystic ovarian syndrome." Journal of Medical and Allied Sciences 3 (2013), 15-21.



MLA (The Modern Language Association) Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar. "Association of DNA damage and dyslipidemia with polycystic ovarian syndrome." Journal of Medical and Allied Sciences 3.1 (2013), 15-21. Print.



APA (American Psychological Association) Style

R. Manikkumar, D. Dinesh Roy, Viji Krishnan, T. Vijayakumar (2013) Association of DNA damage and dyslipidemia with polycystic ovarian syndrome. Journal of Medical and Allied Sciences, 3 (1), 15-21.